Roberts Glore & CO Inc Abbott Laboratories Transaction History

Roberts Glore & CO Inc

  • $341 Million
  • Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Roberts Glore & CO Inc holds 58,017 shares of ABT stock, worth $6.54 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
58,017
Previous 58,876 1.46%
Holding current value
$6.54 Million
Previous $6.12 Million 8.12%
% of portfolio
1.94%
Previous 1.86%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $85,960 - $101,473
-859 Reduced 1.46%
58,017 $6.61 Million
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $57,516 - $64,203
571 Added 0.98%
58,876 $6.12 Million
Q1 2024

May 09, 2024
SELL
$109.52 - $120.96 $644,634 - $711,970
-5,886 Reduced 9.17%
58,305 $6.63 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $821,360 - $1.01 Million
-9,107 Reduced 12.42%
64,191 $7.07 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $1,528 - $1,833
16 Added 0.02%
73,298 $7.1 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $75,081 - $83,656
-745 Reduced 1.01%
73,282 $7.99 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $51,529 - $60,653
532 Added 0.72%
74,027 $7.5 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $184,416 - $216,348
-1,940 Reduced 2.57%
73,495 $8.07 Million
Q3 2022

Nov 07, 2022
SELL
$96.76 - $112.03 $45,477 - $52,654
-470 Reduced 0.62%
75,435 $7.3 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $396,848 - $479,662
-3,888 Reduced 4.87%
75,905 $8.25 Million
Q1 2022

May 02, 2022
SELL
$114.02 - $139.04 $8.8 Million - $10.7 Million
-77,179 Reduced 49.17%
79,793 $9.44 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $7.01 Million - $8.58 Million
60,649 Added 62.96%
156,972 $22.1 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $210,104 - $232,437
-1,801 Reduced 1.84%
96,323 $11.4 Million
Q2 2021

Aug 10, 2021
SELL
$105.79 - $124.53 $426,651 - $502,229
-4,033 Reduced 3.95%
98,124 $11.4 Million
Q1 2021

May 06, 2021
SELL
$108.84 - $128.23 $362,654 - $427,262
-3,332 Reduced 3.16%
102,157 $12.2 Million
Q4 2020

Feb 09, 2021
SELL
$105.0 - $114.42 $69,300 - $75,517
-660 Reduced 0.62%
105,489 $11.6 Million
Q3 2020

Nov 06, 2020
SELL
$91.64 - $111.29 $169,717 - $206,109
-1,852 Reduced 1.71%
106,149 $11.6 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $225,498 - $288,610
-2,945 Reduced 2.65%
108,001 $9.88 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $10,365 - $15,156
-165 Reduced 0.15%
110,946 $8.75 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $5.76 Million - $6.41 Million
73,349 Added 194.24%
111,111 $9.65 Million
Q3 2019

Nov 08, 2019
SELL
$81.84 - $88.74 $24,224 - $26,267
-296 Reduced 0.78%
37,762 $3.16 Million
Q2 2019

Aug 09, 2019
SELL
$72.88 - $85.0 $88,403 - $103,105
-1,213 Reduced 3.09%
38,058 $3.2 Million
Q1 2019

May 14, 2019
SELL
$66.22 - $80.06 $100,190 - $121,130
-1,513 Reduced 3.71%
39,271 $3.14 Million
Q4 2018

Feb 08, 2019
SELL
$65.56 - $74.27 $129,087 - $146,237
-1,969 Reduced 4.61%
40,784 $2.95 Million
Q3 2018

Nov 09, 2018
BUY
$60.81 - $73.36 $13,195 - $15,919
217 Added 0.51%
42,753 $3.14 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $20,955 - $23,128
-364 Reduced 0.85%
42,536 $2.59 Million
Q1 2018

May 08, 2018
BUY
$56.27 - $63.62 $7,934 - $8,970
141 Added 0.33%
42,900 $2.57 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $21,472 - $22,988
-400 Reduced 0.93%
42,759 $2.44 Million
Q3 2017

Nov 08, 2017
SELL
$48.06 - $53.64 $21,819 - $24,352
-454 Reduced 1.04%
43,159 $2.3 Million
Q2 2017

Aug 15, 2017
BUY
N/A
43,613
43,613 $2.12 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email